​

Progyny (PGNY) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

PGNY Stock Forecast

Progyny (PGNY) stock forecast, based on 20 Wall Street analysts, predicts a 12-month average price target of $31.60, with a high of $35.00 and a low of $28.00. This represents a 28.82% increase from the last price of $24.53.

$15 $20 $25 $30 $35 $40 High: $35 Avg: $31.6 Low: $28 Last Closed Price: $24.53

PGNY Stock Rating

Progyny stock's rating consensus is Buy, based on 20 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 13 Buy (65.00%), 7 Hold (35.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 20 0 7 13 Strong Sell Sell Hold Buy Strong Buy

PGNY Price Target Upside V Benchmarks

TypeNameUpside
StockProgyny28.82%
SectorHealthcare Stocks 15.45%
IndustryHealthcare Information Services Stocks 33.80%

Price Target Trends

1M3M12M
# Anlaysts358
Avg Price Target$33.67$32.00$29.75
Last Closing Price$24.53$24.53$24.53
Upside/Downside37.26%30.45%21.28%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 26164--11
Dec, 25-64--10
Nov, 25-55--10
Oct, 25-55--10
Sep, 25-55--10
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jan 21, 2026J.P. Morgan$35.00$25.2838.45%42.68%
Jan 08, 2026Jailendra SinghTruist Financial$34.00$28.2320.44%38.61%
Jan 08, 2026Scott SchoenhausKeyBanc$32.00$26.8019.40%30.45%
Dec 08, 2025Peter WarendorfBarclays$29.00$24.7017.41%18.22%
Nov 11, 2025KeyBanc$30.00$23.8126.00%22.30%
Aug 08, 2025Sarah JamesRaymond James$28.00$22.2226.01%14.15%
Jul 17, 2025Jailendra SinghTruist Financial$27.00$23.0517.14%10.07%
Feb 28, 2025Canaccord Genuity$23.00$22.532.09%-6.24%
Nov 13, 2024Glen SantangeloJefferies$19.00$21.61-12.08%-22.54%
Nov 13, 2024Sarah JamesCantor Fitzgerald$22.00$21.611.80%-10.31%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jan 21, 2026BTIGBuyBuyhold
Jan 20, 2026CitigroupOutperformupgrade
Jan 12, 2026Bank of America SecuritiesBuyBuyhold
Jan 08, 2026KeyBancOverweightOverweighthold
Dec 08, 2025BarclaysOverweightinitialise
Nov 11, 2025KeyBancSector WeightOverweightupgrade
Aug 08, 2025Cantor FitzgeraldOverweightOverweighthold
Nov 13, 2024JefferiesBuyBuyhold
Nov 13, 2024Cantor FitzgeraldOverweightOverweighthold
Sep 20, 2024Truist FinancialMarket PerformMarket Performhold

Financial Forecast

EPS Forecast

Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$0.74$0.33$0.65$0.59----
Avg Forecast$0.54$0.28$0.59$0.54$0.60$0.90$1.26$1.41
High Forecast$0.57$0.29$0.61$0.55$0.68$1.27$1.44$1.45
Low Forecast$0.51$0.27$0.58$0.53$0.52$0.63$1.11$1.36
Surprise %37.04%17.86%10.17%9.26%----

Revenue Forecast

$0 $400M $800M $1B $2B $2B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$500.62M$786.91M$1.09B$1.17B----
Avg Forecast$507.85M$784.27M$1.09B$1.14B$1.16B$1.29B$1.46B$1.65B
High Forecast$533.20M$799.56M$1.10B$1.17B$1.18B$1.30B$1.46B$1.69B
Low Forecast$485.64M$764.43M$1.06B$1.13B$1.14B$1.29B$1.46B$1.61B
Surprise %-1.42%0.34%-0.38%1.98%----

Net Income Forecast

$0 $30M $60M $90M $120M $150M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$65.77M$30.36M$62.04M$54.34M----
Avg Forecast$54.03M$108.97M$62.04M$54.38M$60.07M$77.16M$128.36M$141.44M
High Forecast$57.53M$130.76M$74.44M$55.77M$68.28M$128.28M$144.97M$145.51M
Low Forecast$50.96M$87.17M$49.63M$53.00M$51.86M$63.12M$111.75M$136.60M
Surprise %21.73%-72.14%--0.08%----

PGNY Forecast FAQ

Is Progyny stock a buy?

Progyny stock has a consensus rating of Buy, based on 20 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 13 Buy, 7 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Progyny is a favorable investment for most analysts.

What is Progyny's price target?

Progyny's price target, set by 20 Wall Street analysts, averages $31.6 over the next 12 months. The price target range spans from $28 at the low end to $35 at the high end, suggesting a potential 28.82% change from the previous closing price of $24.53.

How does Progyny stock forecast compare to its benchmarks?

Progyny's stock forecast shows a 28.82% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the healthcare information services stocks industry (33.80%).

What is the breakdown of analyst ratings for Progyny over the past three months?

  • January 2026: 9.09% Strong Buy, 54.55% Buy, 36.36% Hold, 0% Sell, 0% Strong Sell.
  • December 2025: 0% Strong Buy, 60.00% Buy, 40.00% Hold, 0% Sell, 0% Strong Sell.
  • November 2025: 0% Strong Buy, 50.00% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.

What is Progyny’s EPS forecast?

Progyny's average annual EPS forecast for its fiscal year ending in December 2025 is $0.6, marking a 1.69% increase from the reported $0.59 in 2024. Estimates for the following years are $0.9 in 2026, $1.26 in 2027, and $1.41 in 2028.

What is Progyny’s revenue forecast?

Progyny's average annual revenue forecast for its fiscal year ending in December 2025 is $1.16B, reflecting a -0.71% decrease from the reported $1.17B in 2024. The forecast for 2026 is $1.29B, followed by $1.46B for 2027, and $1.65B for 2028.

What is Progyny’s net income forecast?

Progyny's net income forecast for the fiscal year ending in December 2025 stands at $60.07M, representing an 10.55% increase from the reported $54.34M in 2024. Projections indicate $77.16M in 2026, $128.36M in 2027, and $141.44M in 2028.